Photo from wikipedia
The prokinetic agent cisapride is effective for the treatment of gastroesophageal reflux disease (GERD) in infants and children, but is no longer used for this purpose because of safety concerns.… Click to show full abstract
The prokinetic agent cisapride is effective for the treatment of gastroesophageal reflux disease (GERD) in infants and children, but is no longer used for this purpose because of safety concerns. Therefore, other pharmacological agents need to be investigated for efficacy in GERD treatment. In this study, we examined the effectiveness and safety of mosapride for the treatment of neurologically impaired children and adolescents with GERD.
Keywords:
mosapride gastroesophageal;
neurologically impaired;
reflux disease;
gastroesophageal reflux
Journal Title: Pediatrics International
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Pediatrics International
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!